STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance-Reference-Cited by-同舟云学术

STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance

Published:2016-02 Issue:2 Volume:48 Page:e212-e212
ISSN:2092-6413
Container-title:Experimental & Molecular Medicine
language:en
Short-container-title:Exp Mol Med

Author:

Kim Yoon-Jung,Kang Young,Park Hye-Yeon,Lee Jae-Ran,Yu Dae-Yeul,Murata Takuya,Gondo Yoichi^ORCID,Hwang Jung Hwan,Kim Yong-Hoon,Lee Chul-Ho,Rhee Myungchull,Han Pyung-Lim,Chung Bong-Hyun,Lee Hyun-Jun,Kim Kyoung-Shim

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

http://www.nature.com/articles/emm20161.pdf

Reference52 articles.

1. Di-Chiara G, Imperato A . Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274–5278.

2. Wise RA, Bozarth MA . A psychomotor stimulant theory of addiction. Psychol Rev 1987; 94: 469–492.

3. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F . Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 2011; 108: 15037–15042.

4. Law PY, Wong YH, Loh HH . Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 2000; 40: 389–430.

5. Wang H, Moriwaki A, Wang JB, Uhl GR, Pickel VM . Ultrastructural immunocytochemical localization of μ-opioid receptors in dendritic targets of dopaminergic terminals in the rat caudate-putamen nucleus. Neuroscience 1997; 81: 757–771.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoplasmonic immunosensor for the detection of SCG2, a candidate serum biomarker for the early diagnosis of neurodevelopmental disorder;Scientific Reports;2021-11-23

2. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease;Nutrition Research;2021-02

3. Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging;Neuropharmacology;2020-09

4. NQO1 regulates pharmaco-behavioral effects of d-amphetamine in striatal dopaminergic system in mice;Neuropharmacology;2020-06

5. The day‐night differences in ERK1 /2, GSK3β activity and c‐Fos levels in the brain, and the responsiveness of various brain structures to morphine;Journal of Comparative Neurology;2020-03-29